AnaptysBio Inc Stock
AnaptysBio Inc Stock
AnaptysBio Inc gained 1.850% today.
We see a rather positive sentiment for AnaptysBio Inc with 8 Buy predictions and 1 Sell predictions.
With a target price of 45 € there is potential for a 104.55% increase which would mean more than doubling the current price of 22.0 € for AnaptysBio Inc.
Pros and Cons of AnaptysBio Inc in the next few years
Pros
?
M***** P*******
?
B****
?
C******** o* t** e**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of AnaptysBio Inc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
AnaptysBio Inc | 1.850% | 0.000% | -11.290% | 26.437% | 13.402% | 13.990% | - |
Immunic Inc. | 3.450% | -1.821% | -8.042% | -23.565% | -20.839% | -89.848% | - |
NanoViricides Inc. | 0.920% | 12.245% | 113.592% | 103.704% | 132.804% | -26.471% | -48.308% |
Ocuphire Pharma Inc. | 1.010% | -4.064% | -9.942% | -58.453% | -44.258% | - | - |
Comments
AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $34.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $47.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio, Inc. (NASDAQ: ANAB) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $34.00 price target on the stock, up previously from $20.00.
Show more
Ratings data for ANAB provided by MarketBeat
News
Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week
Many stocks were wobbly over the past few trading days, but we can't say that about biotech AnaptysBio (NASDAQ: ANAB). The company's shares closed the week almost 8% higher in price, according to